ProMIS Neurosciences Inc.
Pharmaceutical company · Toronto, Ontario, Canada · Nasdaq: PMN
ProMIS Neurosciences Inc. is a pharmaceutical company headquartered in Toronto, Ontario, Canada. Its shares trade on Nasdaq under the ticker PMN. It has reported private securities offerings to the US SEC, most recently $7.5 million sold in a notice filed in 2022.
ProMIS Neurosciences at a glance
What does ProMIS Neurosciences do?
Private fundraising reported to the SEC
30 Form D notices; the most recent reported $7.5 million sold (2022).
Frequently asked questions about ProMIS Neurosciences
Where is ProMIS Neurosciences headquartered?
ProMIS Neurosciences Inc. is headquartered in Toronto, Ontario, Canada.
What does ProMIS Neurosciences do?
ProMIS Neurosciences Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is ProMIS Neurosciences a public company?
Yes. ProMIS Neurosciences Inc. trades on Nasdaq under the ticker PMN.
Similar companies
- Medicenna Therapeutics Corp.Toronto, Ontario, Canada
- Quantum Biopharma Ltd.Toronto, Ontario, Canada
- Psyence Biomedical Ltd.Toronto, Ontario, Canada
- Intellipharmaceutics International Inc.Toronto, Ontario, Canada
- Avicanna Inc.Toronto, Ontario, Canada
- Bradmer Pharmaceuticals IncToronto, Ontario, Canada
- Organigram Global Inc.Toronto, Ontario, Canada
- Sunovion CNS Development Canada UlcToronto, Ontario, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences